THE NEW PROSPECT FOR BODY CONTROL ?

Experts are rapidly investigating retatrutide, a novel treatment from Eli Lilly, as a potential step in weight management. Different than many previous approaches, retatrutide is a double -action compound targeting both GLP-1 and GIP, substances that affect appetite and blood glucose control . P